Verici Dx plc (AIM:VRCI)
London · Delayed Price · Currency is GBP · Price in GBX 0.8748
-0.0002 (-0.02%)
Dec 5, 2025, 4:26 PM GMT+1
Verici Dx Market Cap
Verici Dx has a market cap or net worth of 12.86 million as of December 5, 2025. Its market cap has increased by 57.15% in one year.
Market Cap
12.86M
Enterprise Value
12.73M
Revenue
1.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.87
Market Cap Chart
Since November 3, 2020, Verici Dx's market cap has decreased from 51.74M to 12.86M, a decrease of -75.14%. That is a compound annual growth rate of -23.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 12.86M | 36.87% |
| Dec 31, 2024 | 9.40M | -43.40% |
| Dec 29, 2023 | 16.61M | -22.00% |
| Dec 30, 2022 | 21.29M | -71.66% |
| Dec 31, 2021 | 75.13M | -9.40% |
| Dec 31, 2020 | 82.92M | 60.27% |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 209.56B |
| GSK plc | 73.29B |
| Haleon | 32.02B |
| Smith & Nephew | 10.44B |
| Convatec Group | 4.45B |
| Hikma Pharmaceuticals | 3.52B |
| HUTCHMED (China) | 1.84B |
| Genus | 1.77B |